We hypothesized that SGOL1 expression level could be correlated with the expression levels of immune checkpoints in HCC tumors to achieve immune evasion by suppressing T cell function, further promoting HCC progression, which is a complex process, and the exact promotion mechanism still needs to be clarified. Here, SGO1 is linked to hepatocellular carcinoma.